Molecules and Cells

  • 제41권10호
  • /
  • Pages.917-922
  • /
  • 2018
  • /
  • 1016-8478(pISSN)
  • /
  • 0219-1032(eISSN)
한국분자세포생물학회 (Korean Society for Molecular and Cellular Biology)
권호 표지
DOI QR코드

DOI QR Code

Editing of Genomic TNFSF9 by CRISPR-Cas9 Can Be Followed by Re-Editing of Its Transcript

  • Lee, Hyeon-Woo (Institute of Oral Biology, School of Dentistry, Graduate School, Kyung Hee University)
  • 투고 : 2018.05.15
  • 심사 : 2018.08.14
  • 발행 : 2018.10.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The CRISPR-Cas system is a well-established RNA-guided DNA editing technique widely used to modify genomic DNA sequences. I used the CRISPR-Cas9 system to change the second and third nucleotides of the triplet $T{\underline{CT}}$ of human TNSFSF9 in HepG2 cells to $T{\underline{AG}}$ to create an amber stop codon. The $T{\underline{CT}}$ triplet is the codon for Ser at the $172^{nd}$ position of TNSFSF9. The two substituted nucleotides, AG, were confirmed by DNA sequencing of the PCR product followed by PCR amplification of the genomic TNFSF9 gene. Interestingly, sequencing of the cDNA of transcripts of the edited TNFSF9 gene revealed that the $T{\underline{AG}}$ had been re-edited to the wild type triplet $T{\underline{CT}}$, and 1 or 2 bases just before the triplet had been deleted. These observations indicate that CRISPR-Cas9-mediated editing of bases in target genomic DNA can be followed by spontaneous re-editing (correcting) of the bases during transcription.

키워드

참고문헌

  1. Baltimore, D., Berg, P., Botchan, M., Carroll, D., Charo, R.A., Church, G., Corn, J.E., Daley, G.Q., Doudna, J.A., Fenner, M., et al. (2015). Biotechnology. A prudent path forward for genomic engineering and germline gene modification. Science 348, 36-38. https://doi.org/10.1126/science.aab1028
  2. Bibikova, M., Golic, M., Golic, K.G., and Carroll, D. (2002). Targeted chromosomal cleavage and mutagenesis in drosophila using zincfinger nucleases. Genetics 161, 1169-1175.
  3. Bibikova, M., Beumer, K., Trautman, J.K., and Carroll, D. (2003). Enhancing gene targeting with designed zinc finger nucleases. Science 300, 764. https://doi.org/10.1126/science.1079512
  4. Boch, J., Scholze, H., Schornack, S., Landgraf, A., Hahn, S., Kay, S., Lahaye, T., Nickstadt, A., and Bonas, U. (2009). Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326, 1509-1512. https://doi.org/10.1126/science.1178811
  5. Choulika, A., Perrin, A., Dujon, B., and Nicolas, J.F. (1995). Induction of homologous recombination in mammalian chromosomes by using the I-SceI system of Saccharomyces cerevisiae. Mol. Cell. Biol. 15, 1968-1973. https://doi.org/10.1128/MCB.15.4.1968
  6. Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X., Jiang, W., Marraffini, L.A., and Zhang, F. (2013). Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823. https://doi.org/10.1126/science.1231143
  7. Cox, D.B.T., Gootenberg, J.S., Abudayyeh, O.O., Franklin, B., Kellner, M.J., Joung, J., Zhang, F. (2017). RNA editing with CRISPR-Cas13. Science 358, 1019-1027. https://doi.org/10.1126/science.aaq0180
  8. Davis, K.M., Pattanayak, V., Thompson, D.B., Zuris, J.A., and Liu, D.R. (2015). Small molecule-triggered Cas9 protein with improved genome-editing specificity. Nat. Chem. Biol. 11, 316-318. https://doi.org/10.1038/nchembio.1793
  9. Deveau, H., Barrangou, R., Garneau, J.E., Labonte, J., Fremaux, C., Boyaval, P., Romero, D.A., Horvath, P., and Moineau, S. (2008). Phage response to CRISPR-encoded resistance in streptococcus thermophilus. J. Bacteriol. 190, 1390-1400. https://doi.org/10.1128/JB.01412-07
  10. Doudna, J.A., and Charpentier, E. (2014). Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346, 1258096. https://doi.org/10.1126/science.1258096
  11. Garneau, J.E., Dupuis, M.E., Villion, M., Romero, D.A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadan, A.H., and Moineau. S. (2010). The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468, 67-71. https://doi.org/10.1038/nature09523
  12. Gasiunas, G., Barrangou, R., Horvath, P., and Siksnys, V. (2012). Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. USA 109, E2579-E2586. https://doi.org/10.1073/pnas.1208507109
  13. Hsu, P.D., Lander, E.S., and Zhang, F. (2014). Development and applications of CRISPR-Cas9 for genome engineering. Cell 157, 1262-1278. https://doi.org/10.1016/j.cell.2014.05.010
  14. Jasin. M. (1996). Genetic manipulation of genomes with rare-cutting endonucleases. Trends Genet. 12, 224-228. https://doi.org/10.1016/0168-9525(96)10019-6
  15. Jeggo, P.A. (1998). DNA breakage and repair. Adv. Genet. 38, 185-218.
  16. Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J.A., and Charpentier, E. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816-821. https://doi.org/10.1126/science.1225829
  17. Kable, M.L., Seiwert, S.D., Heidmann, S., and Stuart, K. (1996). RNA editing: a mechanism for gRNA-specified uridylate insertion into precursor mRNA. Science 273, 1189-1195. https://doi.org/10.1126/science.273.5279.1189
  18. Kim, D.K., Lee, S.C., and Lee, H.W. (2009). CD137 ligand-mediated reverse signals increase cell viability and cytokine expression in murine myeloid cells: Involvement of mTOR/p70S6 kinase and Akt. Eur. J. Immunol. 39, 2617-2628. https://doi.org/10.1002/eji.200939292
  19. Kim, E.C., Moon, J.H., Kang, S.W., Kwon, B., and Lee, H.W. (2015). TMEM126A, a CD137 ligand binding protein, couples with the TLR4 signal transduction pathway in macrophages. Mol. Immunol. 64, 244-251. https://doi.org/10.1016/j.molimm.2014.12.001
  20. Komor, A.C., Kim, Y.B., Packer, M.S., Zuris, J.A., and Liu, D.R. (2016). Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420-424. https://doi.org/10.1038/nature17946
  21. Komor, A.C., Badran, A.H., and David R.L. (2017). CRISPR-Based technologies for the manipulation of eukaryotic genomes. Cell 168, 20-36. https://doi.org/10.1016/j.cell.2016.10.044
  22. Koo, T., Lee, J., and Kim J.S. (2015). Measuring and reducing Off-Target activities of programmable nucleases including CRISPR-Cas9. Mol. Cells 38, 475-481. https://doi.org/10.14348/molcells.2015.0103
  23. Lee, H.W., Park, S.J., Choi, B.K., Kim, H.H., Nam, K.O., and Kwon, B.S. (2002). 4-1BB promotes the survival of CD8(+) T lymphocytes by increasing expression of Bcl-x(L) and BfI-1. J. Immunol. 169, 4882-4888. https://doi.org/10.4049/jimmunol.169.9.4882
  24. Lee, H.S., Guo, J., Lemke, E.A., Dimla, R.D., and Schultz, P.G. (2009). Genetic incorporation of a small, environmentally sensitive, fluorescent probe into proteins in Saccharomyces cerevisiae. J. Am. Chem. Soc. 131, 12921-12923. https://doi.org/10.1021/ja904896s
  25. Li, T., Huang, S., Jiang, W.Z., Wright, D., Spalding, M.H., Weeks, D.P., and Yang, B. (2011a). TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain. Nucleic Acids Res. 39, 359-372. https://doi.org/10.1093/nar/gkq704
  26. Li, T., Huang, S., Zhao, X., Wright, D.A., Carpenter, S., Spalding, M.H., Weeks, D.P., and Yang, B. (2011b). Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes. Nucleic Acids Res. 39, 6315-6325. https://doi.org/10.1093/nar/gkr188
  27. Lin, F.L., Sperle, K., and Sternberg, N. (1985). Recombination in mouse L cells between DNA introduced into cells and homologous chromosomal sequences. Proc. Natl. Acad. Sci. USA 82, 1391-1395. https://doi.org/10.1073/pnas.82.5.1391
  28. Mali, P., Aach, J., Stranges, P.B., Esvelt, K.M., Moosburner, M., Kosuri, S., Yang, L., and Church, G.M. (2013). CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat. Biotechnol. 31, 833-838. https://doi.org/10.1038/nbt.2675
  29. Ran, F.A., Hsu, P.D., Lin, C.Y., Gootenberg, J.S., Konermann, S., Trevino, A.E., Scott, D.A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013). Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154, 1380-1389. https://doi.org/10.1016/j.cell.2013.08.021
  30. Shao, Z., and Schwarz, H. (2011). CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction. J. Leukocyte Biol. 89, 21-29. https://doi.org/10.1189/jlb.0510315
  31. Summerer, D., Chen, S., Wu, N., Deiters, A., Chin, J.W., and Schultz, P.G. (2006). A genetically encoded fluorescent amino acid. Proc. Natl. Acad. Sci. USA 103, 9785-9789. https://doi.org/10.1073/pnas.0603965103
  32. Wang, C., Lin, G.H., McPherson, A.J., and Watts, T.H. (2009). Immune regulation by 4-1BB and 4-1BBL: complexities and challenges. Immunol. Rev. 229, 192-215. https://doi.org/10.1111/j.1600-065X.2009.00765.x